Literature DB >> 19156374

[Acute coronary syndrome - a challenge for the cooperation between outpatient and inpatient care].

Rolf Dörr1.   

Abstract

Acute coronary syndrome (ACS) summarizes all phases of coronary heart disease, which are imminently life-threatening. In clinical practice, these are unstable angina pectoris, acute myocardial infarction, and sudden cardiac death. As the transitions between these clinical entities are smooth, it has been established during the last years to distinguish patients based on ECG findings in groups with (STEMI) and without ST segment elevation (NSTEMI/unstable angina pectoris). Because of the life-threatening character of this disease, continuous monitoring and immediate diagnostic evaluation are mandatory in all patients with suspected ACS. Regularly, this has to be done in the emergency department of a hospital. As the diagnostic and therapeutic management of ACS necessitates rapid decision-making, an optimal cooperation between outpatient and inpatient departments is essential for maximal therapeutic performance. However, it has been shown that only 20-30% of patients admitted to an emergency department with acute chest pain have ACS and only 10-15% have acute myocardial infarction. About 50% of patients presenting with acute chest pain are part of a low-risk group and do not need hospital admission. On the other hand, 2-8% of patients with acute myocardial infarction are misdiagnosed in interdisciplinary emergency departments and discharged too early in spite of an ongoing life-threatening risk. Therefore, chest pain units (CPUs) were founded in many hospitals to optimize the diagnosis and treatment of ACS and the related consumption of financial resources. A task force of the German Society of Cardiology is presently preparing a consensus paper on the basic requirements for CPUs in Germany. The positioning of CPUs at the gateway between outpatient and inpatient care and the additional need for short-term outpatient exercise testing (stress ECG, stress echocardiography, scintigraphy, stress MRI) after ruling out ACS and myocardial infarction, predestine these facilities for new models of managed care including cardiologists in private practice.

Entities:  

Mesh:

Year:  2008        PMID: 19156374     DOI: 10.1007/s00059-008-3163-8

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  29 in total

Review 1.  [Do drug-eluting stents influence the spectrum of coronary artery bypass surgery?].

Authors:  Klaus Matschke; Sems Malte Tugtekin; Utz Kappert; Friedrich Jung; Jai-Wun Park; Michael Knaut
Journal:  Herz       Date:  2004-03       Impact factor: 1.443

2.  Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.

Authors:  Gerrit J Laarman; Maarten J Suttorp; Maurits T Dirksen; Loek van Heerebeek; Ferdinand Kiemeneij; Ton Slagboom; L Ron van der Wieken; Jan G P Tijssen; Benno J Rensing; Mark Patterson
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

3.  Comparison of bare metal stents versus drug-eluting stents on clinical decision making in patients with previous percutaneous coronary intervention admitted for suspected acute coronary syndrome.

Authors:  Jatin Joshi; Venu Menon; Georgeta Vaidean; Siva Mohan; Jerome Thomas; Robert V Kelly; George A Stouffer
Journal:  Am J Cardiol       Date:  2006-06-12       Impact factor: 2.778

4.  Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.

Authors:  Duk-Woo Park; Seong-Wook Park; Kyoung-Ha Park; Bong-Ki Lee; Young-Hak Kim; Cheol Whan Lee; Myeong-Ki Hong; Jae-Joong Kim; Seung-Jung Park
Journal:  Am J Cardiol       Date:  2006-06-12       Impact factor: 2.778

5.  Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.

Authors:  Keith D Dawkins; Eberhard Grube; Giulio Guagliumi; Adrian P Banning; Krzysztof Zmudka; Antonio Colombo; Leif Thuesen; Karl Hauptman; Jean Marco; William Wijns; Jeffrey J Popma; Joerg Koglin; Mary E Russell
Journal:  Circulation       Date:  2005-11-14       Impact factor: 29.690

6.  Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.

Authors:  Gerald S Werner; Andreas Krack; Gero Schwarz; Dirk Prochnau; Stefan Betge; Hans R Figulla
Journal:  J Am Coll Cardiol       Date:  2004-12-21       Impact factor: 24.094

7.  Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus.

Authors:  Yanai Ben-Gal; Rephael Mohr; Gideon Uretzky; Benjamin Medalion; Alberto Hendler; Natalie Hansson; Itzhak Herz; Yaron Moshkovitz
Journal:  J Thorac Cardiovasc Surg       Date:  2006-10       Impact factor: 5.209

8.  Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis).

Authors:  Ciro Indolfi; Maria Pavia; Italo F Angelillo
Journal:  Am J Cardiol       Date:  2005-05-15       Impact factor: 2.778

9.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

Review 10.  Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

Authors:  Christoph Stettler; Simon Wandel; Sabin Allemann; Adnan Kastrati; Marie Claude Morice; Albert Schömig; Matthias E Pfisterer; Gregg W Stone; Martin B Leon; José Suarez de Lezo; Jean-Jacques Goy; Seung-Jung Park; Manel Sabaté; Maarten J Suttorp; Henning Kelbaek; Christian Spaulding; Maurizio Menichelli; Paul Vermeersch; Maurits T Dirksen; Pavel Cervinka; Anna Sonia Petronio; Alain J Nordmann; Peter Diem; Bernhard Meier; Marcel Zwahlen; Stephan Reichenbach; Sven Trelle; Stephan Windecker; Peter Jüni
Journal:  Lancet       Date:  2007-09-15       Impact factor: 79.321

View more
  5 in total

Review 1.  Wnt-frizzled signaling to G-protein-coupled effectors.

Authors:  H-Y Wang; C C Malbon
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

2.  Image of the month. Massive right atrial thrombus due to heparin-induced thrombocytopenia type II.

Authors:  K R Julian Chun; Dietmar Bänsch; Rudolf Bauer; Carsten Schneider; Karl-Heinz Kuck
Journal:  Herz       Date:  2008-09       Impact factor: 1.443

3.  Anatomical and functional evaluation of the myocardium in patients with acute coronary syndrome (NSTEMI) using MR imaging.

Authors:  A Romagnoli; M Sperandio; M Di Roma; S Giura; C Cicciò; F Della Gatta; G Simonetti
Journal:  Radiol Med       Date:  2010-12-03       Impact factor: 3.469

Review 4.  [Acute thoracic pain: Chest Pain Unit - the certification campaign of the German Society of Cardiology].

Authors:  Frank Breuckmann; Felix Post; Raimund Erbel; Thomas Münzel
Journal:  Herz       Date:  2009-05       Impact factor: 1.443

5.  Diagnostic performance of electrocardiography in the assessment of significant coronary artery disease and its anatomical size in comparison with coronary angiography.

Authors:  Solmaz Mahmoodzadeh; Mansour Moazenzadeh; Hamidreza Rashidinejad; Mehrdad Sheikhvatan
Journal:  J Res Med Sci       Date:  2011-06       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.